Inflammatory Bowel Disease
5 videos · last 6 months shuffled daily, then older videos newest first
▶
25:23 The Stenova Trial: A New Treatment Option with Ontunisertib in Fibrostenosing CD
Florian Rieder of Cleveland Clinic, principal investigator of the Stenova trial, on ontunisertib — an oral, gut-restricted ALK-5 inhibitor — in fibrostenosing Crohn's disease.
▶
1:14 Removing Barriers: How Clinical Trial Sponsors Support Patients
Dr. Erin Forster, director of MUSC Health's Inflammatory Bowel Disease Center, on how trial sponsors can make taking part in research easier for patients.
▶
2:10 The Missing Piece in IBD Treatment? Regenerating the Gut's Protective Barrier Shows Promise
Researchers at Calibr-Skaggs on CLF065, a potential first-in-class regenerative medicine designed to restore the epithelial barrier in inflammatory bowel disease.
▶
22:10 Crohn's & Colitis Foundation on Recruiting Patients for IBD Trials
Gastroenterologist Chung Sang Tse and the Crohn's & Colitis Foundation discuss how the ADEPT trial recruited adults with inflammatory bowel disease, and which recruitment methods actually worked.
▶
4:32 Innovations in Immunology: The Role of VAV1 and MGDs
Monte Rosa Therapeutics on the role of VAV1 in immunology and inflammation, and its approach to targeting a protein previously considered undruggable.